The accumulation of phosphatidylcholine hydroperoxide (PCOOH), a primary oxidation product of phosphatidylcholine (PC), in blood plasma and tissues has been observed in various pathological conditions, including atherosclerosis. However, the biological roles of PCOOH in these conditions remain unknown. To estimate the atherogenicity of PCOOH, we evaluated the effect of PCOOH on THP-1 monocytic cell adherence to immobilized vascular endothelial cell adhesion molecules. THP-1 cell adhesion to intracellular adhesion molecule-1 (ICAM-1) was dosedependently increased by addition of PCOOH. Phosphatidylcholine hydroxide (a hydroxyl analog of PCOOH) also induced THP-1 cell adhesion to ICAM-1, whereas nonoxidized PC, sn-2 truncated PCs, and other hydroperoxide compounds did not affect the adhesion. In the PCOOH-treated cells, obvious protruding F-actin-rich membrane structures were formed, and lymphocyte function-associated antigen-1 (LFA-1) was localized to the protruding structures. Cytochalasin D, an actin polymerization inhibitor, suppressed the PCOOH-induced cell adhesion to ICAM-1 and the membrane protrusions. These results indicate that PCOOH evokes LFA-1-mediated cell adhesion to ICAM-1 via actin cytoskeletal organization, and the mechanism may participate in monocyte adherence to the arterial wall in the initiation of atherosclerosis.-Asai, A., F. Okajima, K. Nakagawa, D. Ibusuki, K. Tanimura, Y. Nakajima, M. Nagao, M. Sudo, T. Harada, T. Miyazawa, and S. Oikawa. Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1. J. Lipid Res. 2009. 50: 957-965.
Supplementary key words lipid oxidationOxidative lipid modifications play important roles in the pathogenesis of atherosclerosis (1-4). Among oxidatively modified lipids, phosphatidylcholine hydroperoxide (PCOOH), a primary oxidation product of phosphatidylcholine (PC), was observed to be accumulated in arterial walls and blood plasma in atherosclerotic rabbits (5). PCOOH was also identified in human atherosclerotic lesions (6, 7). Furthermore, PCOOH accumulation in plasma has been shown in human subjects with pathological conditions such as hyperlipidemia (8, 9), diabetes (10), uremia (9), and alcoholism (11). Because hyperlipidemia and diabetes are strongly associated with increased incidence of atherosclerosis (12-14), higher plasma PCOOH conditions in these patients may be involved in atherogenesis.In the course of phospholipid oxidation, PC is primarily oxidized to PCOOH. Further oxidative modification of PCOOH yields various secondary oxidation products. To date, a number of the secondary oxidation products have been reported to mediate several atherogenic processes (15, 16). For instance, a series of oxidized PCs with a truncated sn-2 acyl group (sn-2-truncated PCs), such as 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC) and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine, activate aortic endothelial cell binding to monocytes (17-19). The sn-2-truncated PCs with a terminal aldehyde gr...